Instil Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Instil Bio and other ETFs, options, and stocks.About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
CEOBronson Crouch
CEOBronson Crouch
Employees14
Employees14
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2018
Founded2018
Employees14
Employees14
TIL Key Statistics
Market cap74.64M
Market cap74.64M
Price-Earnings ratio-0.97
Price-Earnings ratio-0.97
Dividend yield—
Dividend yield—
Average volume58.85K
Average volume58.85K
High today$11.40
High today$11.40
Low today$10.84
Low today$10.84
Open price$11.08
Open price$11.08
Volume33.94K
Volume33.94K
52 Week high$42.79
52 Week high$42.79
52 Week low$10.70
52 Week low$10.70
Stock Snapshot
As of today, Instil Bio(TIL) shares are valued at $11.17. The company's market cap stands at 74.64M, with a P/E ratio of -0.97.
On 2025-12-10, Instil Bio(TIL) stock moved within a range of $10.84 to $11.40. With shares now at $11.17, the stock is trading +3.0% above its intraday low and -2.0% below the session's peak.
Trading volume for Instil Bio(TIL) stock has reached 33.94K, versus its average volume of 58.85K.
Over the past 52 weeks, Instil Bio(TIL) stock has traded between a high of $42.79 and a low of $10.70.
Over the past 52 weeks, Instil Bio(TIL) stock has traded between a high of $42.79 and a low of $10.70.
People also own
Based on the portfolios of people who own TIL. This list is generated using Robinhood data, and it’s not a recommendation.